Skip to main content
. 2012 Nov;56(11):5476–5483. doi: 10.1128/AAC.00712-12

Table 5.

Microbiological response of eradication at test-of-cure visit (ME population)

Baseline pathogen No. with eradication with drug/no. tested (%)
% Difference (95% CI)
TD-1792 Vancomycin
Any pathogen 59/63 (93.7) 58/63 (92.1) 1.6 (−8.0, 11.1)
S. aureus 49/52 (94.2) 51/55 (92.7) 1.5 (−8.8, 11.5)
    MRSA 36/38 (94.7) 34/37 (91.9) 2.8 (−9.8, 15.3)
    MSSA 11/12 (91.7) 17/18 (94.4) −2.8 (−26.8, 18.3)
Streptococcus agalactiae 3/3 (100) 3/3 (100)